Skip to main content
. 2006 Jul;74(7):3939–3945. doi: 10.1128/IAI.00101-06

FIG. 3.

FIG. 3.

ELISA evaluation of patient seroreactivities to L. infantum recombinant proteins and LiSLA. Sera from patients with visceral leishmaniasis (VL, n = 10), cutaneous leishmaniasis (CL, n = 10), tuberculosis (TB, n = 10), and malaria (n = 6) and sera from healthy controls in the United States (n = 10) were used. The mean and standard error of the mean of the OD values for each group are shown.